G32 (Ayurvedic drug) - an affordable alternative to Chlorhexidine in treating bad breath

Evaluation of the efficacy of G32 (commercially available Ayurvedic preparation) in reducing Halitosis as compared to Chlorhexidine

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2012/05/002695

Enrollment

Registered

2012-05-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with halitosis

Interventions

Intervention1: G32 tablets: G32 is an ayurvedic drug Control Intervention1: chlorhexidine gel: it is the gold standard for treating halitosis

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subjects willing to participate. 2) Subjects with the volatile sulphur compound and hydrocarbon gas levels more than 3.

Exclusion criteria

Exclusion criteria: 1) Subjects who are smokers. 2) Subjects undergoing antibiotic or other antimicrobial therapy. 3) Subjects with any medically compromised conditions contraindicating the oral examination. 4) Subjects with active periodontitis and multiple carious lesions.

Design outcomes

Primary

Measure	Time frame
reduction of the volatile sulphur compounds scoreTimepoint: baseline and one week follow-up	—

Secondary

Measure	Time frame
reduction of the gingival and plaque scoresTimepoint: baseline and one week follow-up	—

Countries

India

Contacts

Public Contactsnehal patil

manipal college of dental sciences manipal

shashidhar.acharya@gmail.com9448127031

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026